Phase 2 LINNAEA Study Presented at EURETINA

Non-Regulatory

September 9, 2021

Solna, Sweden, September 9, 2021. Affibody AB (“Affibody”) today announced that Professor Quan Dong Nguyen, Principal Coordinating Investigator of the LINNAEA Study, that will investigate izokibep (ABY-035) in uveitis, will present at the European Society of Retina Specialists virtual conference EURETINA 2021.

Professor Quan Dong Nguyen, MD, MSc, FARVO, Principal Coordinating Investigator of the LINNAEA Study, and Professor of Ophthalmology at the Byers Eye Institute, Stanford University School of Medicine, USA, will give a presentation on the topic of “New biological treatments of posterior uveitis” at the EURETINA Uveitis Endophthalmitis session Thursday, 9th September, 2021 at 16:45 CEST.